medigraphic.com

2013, Number 6

<< Back Next >>

Cir Cir 2013; 81 (6)

Adult cancer epidemiology at the Oncology Hospital of “Centro Médico Nacional Siglo XXI” from Instituto Mexicano del Seguro Social

Martínez-Sánchez YL, Escudero-de los Ríos PM, Arias-Flores R, Barrios-Bautista F

Language: Spanish
References: 20
Page: 508-516
PDF size: 533.48 Kb.


ABSTRACT

Background: Cancer is one of the main leading death causes in the country, but in terms of morbidity there is no valid register. The aim of this study is to describe the frequency, type, distribution and trend of morbidity and death that have to do with cancer in a concentration hospital.
Methods: A cross-sectional study was performed in care cases first from December 26th, 2005 to December 25th, 2012 at the Oncology Hospital of “Centro Médico Nacional Siglo XXI” from Instituto Mexicano del Seguro Social, in which hospital deaths and patients outflows were included.
Results: A total of 74,402 morbidity cases were identified, in which cancer prevalence by sex was 59.9% in women and 40.1% in men and having an overall median age of 59 years old.
Radiotherapy was the service with more cancer cases with 22.9%. The most common cancers were: breast cancer 17.4%; colon and rectum cancer 6.2%; cervical cancer 5.2%; and skin cancer 5.1%. The leading type of cancer in women was breast cancer with 28.9%, whereas in men was the prostate cancer with 12.3%. We obtained an overall mortality of 4.91, in which 1825 registered deaths are mainly haematological disorders. Breast, prostate and thyroid cancers have shown a rising trend within the last 8 years.
Conclusion: Breast, prostate and colon and rectum cancers are the most common ailments demanding care in concentration hospitals.


REFERENCES

  1. Omran AR. The epidemiologic transition. A theory of the Epidemiology of Population Change. Milbank Q. 1971;49(4 part. 1):509-538.

  2. Kanavos P. The rising burden of cancer in the developing world. Ann Oncol. 2006;17(Suppl 8):15-23.

  3. Jemal A, Center MM, DeSantis C, Ward EM. Global Patterns of Cancer Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893-1907.

  4. McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol. 2011;22(11):2349-2357.

  5. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-615.

  6. American Cancer Society. Cancer Facts and Figures 2009. (consultado 2013 Junio 1). Disponible en: http://www.cancer.org/ acs/groups/content/@nho/documents/document/500809webpdf.pdf

  7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.

  8. Mohar A, Frías-Mendivil M, Suchil-Bernal L, Mora-Macias T, de la Garza JG. Epidemiología descriptiva de cáncer en el Instituto Nacional de Cancerología de México. Salud Publica Mex. 1997;39(4):253-258.

  9. Acosta CB, González FE, Ramírez RG, Medina RI, Fernández GI, Borja AV. Encuesta Nacional de Salud del Instituto Mexicano del Seguro Social ENCOPRVENIMSS. México, IMSS. 2010 p. 145- 148.

  10. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Cáncer de mama en México: una prioridad apremiante. Salud Publica Mex. 2009;51(Supl 2):S335-S344.

  11. Robles-Castillo J, Ruvalcaba-Limón E, Maffuz A, Rodríguez- Cuevas S. Cáncer de mama en mujeres mexicanas menores de 40 años. Ginecol Obstet Mex. 2011;79(8):482-488.

  12. Charúa-Guindic L, Lagunes-Gasca AA, Villanueva-Herrero JA, Jiménez-Bobadilla B, Avendaño-Espinosa O, Charúa-Levy E. Comportamiento epidemiológico del cáncer de colon y recto en el Hospital General de México. Análisis de 20 años: 1988-2007. Rev Gastroenterol Mex. 2009;74(2):99-104.

  13. Thun MJ, Calle EE, Namboodiri MM, Flanders WD, Coates RJ, Byers T, et al. Risk Factors for Fatal Colon Cancer in a Large Prospective Study. J Natl Cancer Inst. 1992;84(19):1491-1500.

  14. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A, et al. Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920-931.

  15. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando- Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. (Consultado 2013 Junio 1). Disponible en: http://ensanut.insp.mx/informes/ENSANUT2012 ResultadosNacionales.pdf

  16. Rojas-Martínez R, Aguilar-Salinas CA, Jiménez-Corona A, Gómez- Pérez FJ, Barquera S, Lazcano-Ponce E. Prevalence of obesity and metabolic síndrome components in Mexican adults without type 2 diabetes or hypertension. Salud Publica Mex. 2012;54:7-12.

  17. Koushik A, Hunter DJ, Spiegelman D, Beeson WL, van den Brandt PA, Buring JE, et al. Fruits, Vegetables, and Colon Cancer Risk in a Pooled Analysis of 14 Cohort Studies. J Natl Cancer Inst. 2007;99(19):1471-1483.

  18. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121(7):1571-1578.

  19. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. Cervical Cancer. J Natl Compr Canc Netw. 2013;11(3):320-343.

  20. Dirección de Información en Salud. Instituto Mexicano del Seguro Social. (consultado 2013 Junio 1). Disponible en: www. imss.gob.mx/estadisticas/financieras/Documents/2011/02_ PoblacionDerechohabiente.xls.




2020     |     www.medigraphic.com